Literature DB >> 28918444

Left atrial volume computed by 3D rotational angiography best predicts atrial fibrillation recurrence after circumferential pulmonary vein isolation.

Teresa Strisciuglio1,2, Giuseppe Di Gioia1, Sofia Chatzikyriakou2, Etel Silva Garcia2, Emanuele Barbato1,2, Peter Geelen2, Tom De Potter3.   

Abstract

Left atrium (LA) size is a well-studied predictor of atrial fibrillation (AF) recurrence after pulmonary vein isolation (PVI). Yet, there is still little agreement on the best imaging technique to size the LA, and on the most appropriate sizing parameter. Volumetric assessment of LA with three-dimensional rotational angiography (3DRA LA volume index) might be a valid alternative to the commonly used transthoracic echocardiography (TTE LA volume index). The aim of our study was to investigate whether LA volume by 3DRA at the time of PVI is able to predict the risk of atrial fibrillation recurrence. We analysed 352 consecutive patients with symptomatic paroxysmal or persistent atrial fibrillation referred for PVI to our Institution. In all patients, LA volume index (LAVI) was assessed by TTE and by 3DRA. Sinus rhythm was restored after PVI in 348 patients (99%). Average TTE-LAVI and 3DRA-LAVI were 37 ± 12 and 83 ± 18 ml/m2, respectively. At a median follow-up of 19 (12, 24) months, 27% of patients had AF recurrence after the first PVI. At the univariate analysis, persistent AF (p < 0.01), use of anti-arrhythmic drugs (AAD) (p < 0.05) and 3DRA-LAVI (p < 0.01) were significantly associated with AF recurrence. In contrast, none of the echocardiographic parameters considered, including TTE-LAVI, was associated with AF recurrence (p = 0.29). At the multivariate analysis, 3DRA-LAVI was the only independent predictor for AF recurrence (HR 1.01 [1.00-1.03], p = 0.017). Left atrial volume measured with 3DRA is superior to TTE assessment and to AF history in predicting atrial fibrillation recurrence after PVI.

Entities:  

Keywords:  Atrial fibrillation; Catheter ablation; Left atrium volume; Pulmonary vein isolation; Risk stratification

Mesh:

Year:  2017        PMID: 28918444     DOI: 10.1007/s10554-017-1243-7

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  13 in total

1.  Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study.

Authors:  Brian Olshansky; Eliot N Heller; L Brent Mitchell; Mary Chandler; William Slater; Martin Green; Michael Brodsky; Patrick Barrell; H Leon Greene
Journal:  J Am Coll Cardiol       Date:  2005-06-21       Impact factor: 24.094

Review 2.  Left atrial size and function: role in prognosis.

Authors:  Brian D Hoit
Journal:  J Am Coll Cardiol       Date:  2013-11-27       Impact factor: 24.094

3.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Authors:  Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas; Stefan Agewall; John Camm; Gonzalo Baron Esquivias; Werner Budts; Scipione Carerj; Filip Casselman; Antonio Coca; Raffaele De Caterina; Spiridon Deftereos; Dobromir Dobrev; José M Ferro; Gerasimos Filippatos; Donna Fitzsimons; Bulent Gorenek; Maxine Guenoun; Stefan H Hohnloser; Philippe Kolh; Gregory Y H Lip; Athanasios Manolis; John McMurray; Piotr Ponikowski; Raphael Rosenhek; Frank Ruschitzka; Irina Savelieva; Sanjay Sharma; Piotr Suwalski; Juan Luis Tamargo; Clare J Taylor; Isabelle C Van Gelder; Adriaan A Voors; Stephan Windecker; Jose Luis Zamorano; Katja Zeppenfeld
Journal:  Eur J Cardiothorac Surg       Date:  2016-09-23       Impact factor: 4.191

4.  Predictors of Success After a First Circumferential Pulmonary Vein Isolation For Atrial Fibrillation.

Authors:  T De Potter; R Tavernier; D Devos; K Van Beeumen; M Duytschaever
Journal:  J Atr Fibrillation       Date:  2009-04-01

5.  Measurement of left atrial volume in patients undergoing ablation for atrial fibrillation: comparison of angiography and electro-anatomic (CARTO) mapping with real-time three-dimensional echocardiography.

Authors:  Hajo Müller; Haran Burri; Pascale Gentil; René Lerch; Dipen Shah
Journal:  Europace       Date:  2010-02-25       Impact factor: 5.214

6.  Intraprocedural imaging of left atrium and pulmonary veins: a comparison study between rotational angiography and cardiac computed tomography.

Authors:  Charalampos Kriatselis; Sotirios Nedios; Spyridon Akrivakis; Min Tang; Mattias Roser; Jin-Hong Gerds-Li; Eckart Fleck; Michael Orlov
Journal:  Pacing Clin Electrophysiol       Date:  2010-11-18       Impact factor: 1.976

Review 7.  Is pulmonary vein isolation still the cornerstone in atrial fibrillation ablation?

Authors:  T Jared Bunch; Michael J Cutler
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

8.  Underestimation of left atrial size measured with transthoracic echocardiography compared with 3D MDCT.

Authors:  Anish R Koka; James Yau; Carolyn Van Why; Ira S Cohen; Ethan J Halpern
Journal:  AJR Am J Roentgenol       Date:  2010-05       Impact factor: 3.959

9.  Left atrial volume calculated by multi-detector computed tomography may predict successful pulmonary vein isolation in catheter ablation of atrial fibrillation.

Authors:  João Abecasis; Raquel Dourado; António Ferreira; Carla Saraiva; Diogo Cavaco; Katya Reis Santos; Francisco Belo Morgado; Pedro Adragão; Aniceto Silva
Journal:  Europace       Date:  2009-07-23       Impact factor: 5.214

10.  Three-dimensional Rotational Angiography as a Periprocedural Imaging Tool in Atrial Fibrillation Ablation.

Authors:  Tom De Potter; Gazmend Bardhaj; Aniello Viggiano; Keith Morrice; Peter Geelen
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-11-29
View more
  4 in total

Review 1.  Invasive therapies for patients with concomitant heart failure and atrial fibrillation.

Authors:  Wei Wei; Michael Shehata; Xunzhang Wang; Fang Rao; Xianzhan Zhan; Huiming Guo; Xianhong Fang; Hongtao Liao; Jian Liu; Hai Deng; Yang Liu; Yumei Xue; Shulin Wu
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

2.  The Impact of Left Atrial Size in Catheter Ablation of Atrial Fibrillation Using Remote Magnetic Navigation.

Authors:  Xiao-Yu Liu; Hai-Feng Shi; Jie Zheng; Ku-Lin Li; Xiao-Xi Zhao; Shi-Peng Dang; Ying Wu; Yan Cheng; Xiao-Yan Li; Zhi-Ming Yu; Ru-Xing Wang
Journal:  Cardiol Res Pract       Date:  2018-12-05       Impact factor: 1.866

Review 3.  Characterization, Pathogenesis, and Clinical Implications of Inflammation-Related Atrial Myopathy as an Important Cause of Atrial Fibrillation.

Authors:  Milton Packer
Journal:  J Am Heart Assoc       Date:  2020-04-03       Impact factor: 5.501

4.  Correlation between Volumes Determined by Echocardiography and Cardiac MRI in Controls and Atrial Fibrillation Patients.

Authors:  Simona Manole; Claudia Budurea; Sorin Pop; Alin M Iliescu; Cristiana A Ciortea; Stefania D Iancu; Loredana Popa; Mihaela Coman; László Szabó; Vasile Coman; Zoltán Bálint
Journal:  Life (Basel)       Date:  2021-12-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.